Piramal Pharma Ltd.

PPLPHARMA

₹219.87

-1.68% (-3.75)

Market Cap

₹29,650 Cr.

P/E

762.22

About

Piramal Pharma Limited (PPL) provides a wide range of products and services globally through various divisions like Piramal Pharma Solutions (PPS) and Piramal Critical Care (PCC). PPS offers Contract … Read more

Piramal Pharma Limited (PPL) provides a wide range of products and services globally through v… Read more

Low

136

52W Range

High

308

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

2 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Asset turnover is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
ROCE Strength

Roce of the company is not consistently strong
Sales Growth

Unable to calculate due to limited data
Margin Stability

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Verticals - Development

Location Wise Break-Up

Services Break-Up

Operational Metrics

Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Piramal Pharma Ltd. Business

What does Piramal Pharma do?

Piramal Pharma Limited provides a range of products and services through global manufacturing capabilities and distribution networks. Its offerings include integrated Contract Development and Manufacturing, Complex Hospital Generics, and Consumer Healthcare products across multiple countries.

Who are the competitors of Piramal Pharma?

Piramal Pharma major competitors are Suven Pharma, Hikal, Suven Life Sciences, Syngene Internation., Sun Pharma Adv. Res, Dishman Carbogen Amc, Zenotech Laboratorie.
Market Cap of Piramal Pharma is ₹29,650 Crs.
While the median market cap of its peers are ₹4,993 Crs.

Is Piramal Pharma financially stable compared to its competitors?

Piramal Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Piramal Pharma is 3.68 and is ranked 7 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Mar Jun Sep Dec	Sep Dec
Investor Presentation		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Sep Dec
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Piramal Pharma Ltd.

Why Piramal Pharma Is Falling ? - Value Educator

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Piramal Pharma Ltd.